B
PCYC

Baird’s PHARMACYCLICS INC PCYC Stock Holding History

Baird’s Portfolio PCYC Stock Details PCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$235K Buy
+920
New +$178K ﹤0.01% 1177

Other funds holding PCYC

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Baird's PCYC Position: Q1 2015 in Review

Baird opened a new position in PHARMACYCLICS INC (PCYC) in Q1 2015: 920 shares worth $235K. The stake represents ﹤0.01% of the portfolio and ranks #1177 among its holdings.

336 funds tracked by Wall St. Rank hold PCYC as of Q1 2015.

  • Baird held 920 shares of PHARMACYCLICS INC worth $235K as of Q1 2015.
  • PHARMACYCLICS INC was a new Baird position in Q1 2015.
  • PHARMACYCLICS INC made up ﹤0.01% of Baird's portfolio in Q1 2015, its #1177 holding.
  • 336 funds tracked by Wall St. Rank held PHARMACYCLICS INC as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.